'Quadrapeutics' works in preclinical study of hard-to-treat tumors

(Rice University) A Rice University-led study in this week's Nature Medicine reports the first preclinical tests for a novel anti-cancer technology called 'quadrapeutics' that converts current clinical treatments to instantaneously detect and kill only cancer cells. Quadrapeutics combines clinically available drugs, colloidal gold, pulsed lasers and radiation in a novel and safe micro-treatment that improved standard therapy by 17-fold against aggressive, drug-resistant tumors.